Oncolytic virotherapy for prevention of tumor recurrence

US9861669B2 · kind B2 · utility

Assignees

• DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS · DE
• RUPRECHT - KARLS - UNIVERSITÄT HEIDELBERG · DE

Inventors

• Jean Rommelaere · Heidelberg, DE
• Zahari Raykov · Heidelberg, DE
• Svitlana Grekova · Heidelberg, DE
• Irina Kiprijanova · Heidelberg, DE
• Karsten Geletneky · Heidelberg, DE
• Ute Koch · Épalinges, CH
• Marc Aprahamian · Heidelberg, DE

Key dates

• Filing date: May 19, 2010
• Grant date: Jan 9, 2018
• Expiry date: May 19, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2750/14332
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described is a parvovirus for preventing recurrence of a tumor, preferably a malignant brain tumor or pancreas tumor.